Drugs / Centella asiatica water extract
Centella asiatica water extract
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03937908 | Oct 2019 → Dec 2020 | cognitive impairment with or without cerebellar ataxia | Oregon Health and Science University | Terminated | No outcome recorded Stop: Business |
| Phase 0 | NCT03929250 | Jul → Nov 2019 | — | Oregon Health and Science University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Centella asiatica water extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03937908 ↗ |
| Known as | CAP | “Participants will orally consume a single administration of a standardized Centella asiatica water extract product (CAP).” NCT03937908 ↗ |
| Known as | CAW | “2g Centella asiatica water extract product is a powder containing Centella asiatica water extract (CAW) and excipients to improve palatability, color matching and...” NCT03929250 ↗1“2g of Centella asiatica water extract (CAW) in a standardized product containing excipients to improve palatability, color matching and dispersability.” NCT03937908 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Centella asiatica is reputed in Eastern medicine to improve cognitive function in humans.” PMID 35204098 ↗ Jan 2022 |
| Route | Oral | “Participants will orally consume a single administration of a standardized Centella asiatica water extract product (CAP).” NCT03929250 ↗ |